Catalysts for VALPROATE SODIUM
14 tracked
Apr 30, 2026
phase 2 completion
Australasian Gastro-Intestinal Trials Group — valproate sodium (Phase II Trial Completion)
VALPROATE SODIUM
→
Mar 31, 2026
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Mar 31, 2026
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Apr 4, 2024
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Apr 4, 2024
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Oct 11, 2016
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Dec 22, 2015
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Dec 22, 2015
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Dec 22, 2015
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Dec 22, 2015
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Dec 22, 2015
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Oct 24, 2007
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Jun 26, 2003
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→
Nov 14, 2002
approval
VALPROATE SODIUM — FDA approval
VALPROATE SODIUM
→